127 results on '"Neumann, Helmut"'
Search Results
52. Histological diagnosis of acute graft-versus-host disease in different sites of the upper gastrointestinal tract with correlation to endoscopic findings.
- Author
-
Kreft, Andreas, Schulze, Lisa, Ries, Isabelle, Schindeldecker, Mario, and Neumann, Helmut
- Subjects
- *
GASTROINTESTINAL system , *GRAFT versus host disease , *HEMATOPOIETIC stem cell transplantation , *STOMACH - Abstract
Graft-versus-host disease (GvHD) involving the intestine is a threat to patients after allogeneic hematopoietic stem cell transplantation (alloHSCT). We evaluated biopsies from different sites of the upper gastrointestinal tract (GIT) of 97 patients after alloHSCT. Forty-six patients with clinical symptoms consistent with upper GI GvHD revealed histological features of GvHD in the esophagus, stomach, and/or duodenum. Biopsies of the duodenum and esophagus were significantly more sensitive for signs of GvHD than those of the gastric antrum or corpus. The histological features of GvHD were significantly correlated with the endoscopic findings of ulcers, erosion, atrophy, and white plaques; however, the sensitivity and specificity of the latter were low. In univariate analysis, overall mortality was significantly associated with histological GvHD signs in all four sites. Nonrelapse mortality was associated with histologic GvHD features in the antrum only. Regarding GvHD diagnosis, biopsies of the upper gastrointestinal tract should include the duodenum and/or esophagus. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
53. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022.
- Author
-
Pennazio, Marco, Rondonotti, Emanuele, Despott, Edward J., Dray, Xavier, Keuchel, Martin, Moreels, Tom, Sanders, David S., Spada, Cristiano, Carretero, Cristina, Cortegoso Valdivia, Pablo, Elli, Luca, Fuccio, Lorenzo, Gonzalez Suarez, Begona, Koulaouzidis, Anastasios, Kunovsky, Lumir, McNamara, Deirdre, Neumann, Helmut, Perez-Cuadrado-Martinez, Enrique, Perez-Cuadrado-Robles, Enrique, and Piccirelli, Stefania
- Subjects
- *
CAPSULE endoscopy , *SMALL intestine , *ENTEROSCOPY , *ENDOSCOPY , *CROSS-sectional imaging - Abstract
MR1: ESGE recommends small-bowel capsule endoscopy as the first-line examination, before consideration of other endoscopic and radiological diagnostic tests for suspected small-bowel bleeding, given the excellent safety profile of capsule endoscopy, its patient tolerability, and its potential to visualize the entire small-bowel mucosa.Strong recommendation, moderate quality evidence. MR2: ESGE recommends small-bowel capsule endoscopy in patients with overt suspected small-bowel bleeding as soon as possible after the bleeding episode, ideally within 48 hours, to maximize the diagnostic and subsequent therapeutic yield.Strong recommendation, high quality evidence. MR3: ESGE does not recommend routine second-look endoscopy prior to small-bowel capsule endoscopy in patients with suspected small-bowel bleeding or iron-deficiency anemia.Strong recommendation, low quality evidence. MR4: ESGE recommends conservative management in those patients with suspected small-bowel bleeding and high quality negative small-bowel capsule endoscopy.Strong recommendation, moderate quality evidence. MR5: ESGE recommends device-assisted enteroscopy to confirm and possibly treat lesions identified by small-bowel capsule endoscopy.Strong recommendation, high quality evidence. MR6: ESGE recommends the performance of small-bowel capsule endoscopy as a first-line examination in patients with iron-deficiency anemia when small bowel evaluation is indicated.Strong recommendation, high quality evidence. MR7: ESGE recommends small-bowel capsule endoscopy in patients with suspected Crohn's disease and negative ileocolonoscopy findings as the initial diagnostic modality for investigating the small bowel, in the absence of obstructive symptoms or known bowel stenosis.Strong recommendation, high quality evidence. MR8: ESGE recommends, in patients with unremarkable or nondiagnostic findings from dedicated small-bowel cross-sectional imaging, small-bowel capsule endoscopy as a subsequent investigation if deemed likely to influence patient management.Strong recommendation, low quality evidence. MR9: ESGE recommends, in patients with established Crohn's disease, the use of a patency capsule before small-bowel capsule endoscopy to decrease the capsule retention rate.Strong recommendation, moderate quality evidence. MR10: ESGE recommends device-assisted enteroscopy (DAE) as an alternative to surgery for foreign bodies retained in the small bowel requiring retrieval in patients without acute intestinal obstruction.Strong recommendation, moderate quality evidence. MR11: ESGE recommends DAE-endoscopic retrograde cholangiopancreatography (DAE-ERCP) as a first-line endoscopic approach to treat pancreaticobiliary diseases in patients with surgically altered anatomy (except for Billroth II patients).Strong recommendation, moderate quality evidence. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
54. Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative.
- Author
-
Dekker, Evelien, Nass, Karlijn J., Iacucci, Marietta, Murino, Alberto, Sabino, João, Bugajski, Marek, Carretero, Cristina, Cortas, George, Despott, Edward J., East, James E., Kaminski, Michal F., Karstensen, John Gásdal, Keuchel, Martin, Löwenberg, Mark, Monged, Ashraf, Nardone, Olga M., Neumann, Helmut, Omar, Mahmoud M., Pellisé, Maria, and Peyrin-Biroulet, Laurent
- Abstract
The European Society of Gastrointestinal Endoscopy (ESGE) presents a short list of performance measures for colonoscopy in inflammatory bowel disease (IBD) patients. Current performance measures for colonoscopy mainly focus on detecting (pre)malignant lesions. However, these performance measures are not relevant for all colonoscopy indications in IBD patients. Therefore, our aim was to provide endoscopy services across Europe and other interested countries with a tool for quality monitoring and improvement in IBD colonoscopy. Eight key performance measures and one minor performance measure were recommended for measurement and evaluation in daily endoscopy practice. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
55. Performance of a new integrated computer-assisted system (CADe/CADx) for detection and characterization of colorectal neoplasia.
- Author
-
Weigt, Jochen, Repici, Alessandro, Antonelli, Giulio, Afifi, Ahmed, Kliegis, Leon, Correale, Loredana, Hassan, Cesare, and Neumann, Helmut
- Subjects
- *
TUMORS , *ARTIFICIAL intelligence , *INDEPENDENT sets , *POLYPS , *TEST systems , *RESEARCH , *COLON polyps , *COLONOSCOPY , *COMPUTERS , *RESEARCH methodology , *ADENOMA , *EVALUATION research , *COLORECTAL cancer , *COMPARATIVE studies , *RESEARCH funding , *JUNIPERUS communis , *COMPUTER-aided diagnosis - Abstract
Background: Use of artificial intelligence may increase detection of colorectal neoplasia at colonoscopy by improving lesion recognition (CADe) and reduce pathology costs by improving optical diagnosis (CADx).Methods: A multicenter library of ≥ 200 000 images from 1572 polyps was used to train a combined CADe/CADx system. System testing was performed on two independent image sets (CADe: 446 with polyps, 234 without; CADx: 267) from 234 polyps, which were also evaluated by six endoscopists (three experts, three non-experts).Results: CADe showed sensitivity, specificity, and accuracy of 92.9 %, 90.6 %, and 91.7 %, respectively. Experts showed significantly higher accuracy and specificity, and similar sensitivity, while non-experts + CADe showed comparable sensitivity but lower specificity and accuracy than CADe and experts. CADx showed sensitivity, specificity, and accuracy of 85.0 %, 79.4 %, and 83.6 %, respectively. Experts showed comparable performance, whereas non-experts + CADx showed comparable accuracy but lower specificity than CADx and experts.Conclusions: The high accuracy shown by CADe and CADx was similar to that of experts, supporting further evaluation in a clinical setting. When using CAD, non-experts achieved a similar performance to experts, with suboptimal specificity. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
56. ERCP with the overtube-assisted enteroscopy technique: a systematic review.
- Author
-
Skinner, Matthew, Popa, Daniel, Neumann, Helmut, Wilcox, C. Mel, and Mönkemüller, Klaus
- Subjects
- *
ENTEROSCOPY , *ENDOSCOPIC retrograde cholangiopancreatography , *GASTRIC bypass , *CATHETERIZATION , *SURGICAL anastomosis - Abstract
Background and study aim: Overtube-assisted enteroscopy (OAE) techniques have increased the ability to perform endoscopic retrograde cholangiopancreatography (ERCP) in patients with altered upper gastrointestinal anatomy, such as Roux-en-Y gastric bypass. The aim of this study was to compare the efficacy and safety of OAEERCP in patients with different configurations of upper gastrointestinal anatomy. Patients and methods: A systematic review was performed following a literature search for papers published between 1966 and August 2013. The following databases were searched: MEDLINE (via PubMed), Embase, Cochrane library, and Scopus. The following end points were analyzed: diagnostic and therapeutic success rates, cannulation success rate, ERCP success rate, type of enteroscopy, types of intervention, complications. Results: A total of 23 relevant reports on OAE procedures, including single-balloon, double-balloon, and spiral enteroscopy, were analyzed. Studies included a total of 945 procedures in 679 patients (age 2-91 years) who had a variety of postsurgical upper gastrointestinal anatomical configurations. Among patients who underwent Roux-en-Y with gastric bypass, endoscopic success was 80% and ERCP success was 70%. In patients who had undergone a Roux-en-Y with either a pancreaticoduodenectomy, pylorus-preserving pancreaticoduodenectomy, or hepaticojejunostomy, endoscopic success was 85% and ERCP success was 76%. In patients who had undergone a Billroth II procedure, endoscopic success was 96% and ERCP success was 90%. In patients with native papilla who underwent successful endoscopy, cannulation was successful in 90% of patients compared with 92% in patients with an anastomosis. Overall ERCP success for all attempts was approximately 74%. Interventions included sphincterotomy, pre-cut papillotomy, anastomotic stricturoplasty, stone removal, stent insertion, stent replacement, and balloon dilation of stenotic anastomosis. There were 32 major complications among the 945 procedures (3.4 %). Conclusion: Both endoscopic and ERCP success rates were highest in patients with Billroth II anatomy, followed by those with pancreaticoduodenectomy and Roux-en-Y hepaticojejunostomy; the lowest success rates were in patients with Roux-en-Y gastric bypass. Cannulation rates appeared to be equivalent in patients with both native papilla and biliary-enteric or pancreaticoenteric anastomoses. The diagnostic and therapeutic potential of balloon-assisted ERCP were high and the adverse event rate was low. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
57. Intestinal Graft Versus Host Disease Involving Brunner's Glands.
- Author
-
Kreft, Andreas, Wagner, Daniel-Christoph, and Neumann, Helmut
- Subjects
- *
GRAFT versus host disease , *GLANDS , *HEMATOPOIETIC stem cell transplantation , *IMMUNOCOMPETENT cells - Published
- 2020
- Full Text
- View/download PDF
58. Definition of competence standards for optical diagnosis of diminutive colorectal polyps: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.
- Author
-
Houwen, Britt B. S. L., Hassan, Cesare, Coupé, Veerle M. H., Greuter, Marjolein J. E., Hazewinkel, Yark, Vleugels, Jasper L. A., Antonelli, Giulio, Bustamante-Balén, Marco, Coron, Emmanuel, Cortas, George A., Dinis-Ribeiro, Mario, Dobru, Daniela E., East, James E., Iacucci, Marietta, Jover, Rodrigo, Kuvaev, Roman, Neumann, Helmut, Pellisé, Maria, Puig, Ignasi, and Rutter, Matthew D.
- Subjects
- *
COLON polyps , *COLONOSCOPY , *ARTIFICIAL intelligence , *COLORECTAL cancer , *ENDOSCOPIC gastrointestinal surgery - Abstract
BACKGROUND : The European Society of Gastrointestinal Endoscopy (ESGE) has developed a core curriculum for high quality optical diagnosis training for practice across Europe. The development of easy-to-measure competence standards for optical diagnosis can optimize clinical decision-making in endoscopy. This manuscript represents an official Position Statement of the ESGE aiming to define simple, safe, and easy-to-measure competence standards for endoscopists and artificial intelligence systems performing optical diagnosis of diminutive colorectal polyps (1 - 5 mm). METHODS : A panel of European experts in optical diagnosis participated in a modified Delphi process to reach consensus on Simple Optical Diagnosis Accuracy (SODA) competence standards for implementation of the optical diagnosis strategy for diminutive colorectal polyps. In order to assess the clinical benefits and harms of implementing optical diagnosis with different competence standards, a systematic literature search was performed. This was complemented with the results from a recently performed simulation study that provides guidance for setting alternative competence standards for optical diagnosis. Proposed competence standards were based on literature search and simulation study results. Competence standards were accepted if at least 80 % agreement was reached after a maximum of three voting rounds. RECOMMENDATION 1: In order to implement the leave-in-situ strategy for diminutive colorectal lesions (1-5 mm), it is clinically acceptable if, during real-time colonoscopy, at least 90 % sensitivity and 80 % specificity is achieved for high confidence endoscopic characterization of colorectal neoplasia of 1-5 mm in the rectosigmoid. Histopathology is used as the gold standard.Level of agreement 95 %. RECOMMENDATION 2: In order to implement the resect-and-discard strategy for diminutive colorectal lesions (1-5 mm), it is clinically acceptable if, during real-time colonoscopy, at least 80 % sensitivity and 80 % specificity is achieved for high confidence endoscopic characterization of colorectal neoplasia of 1-5 mm. Histopathology is used as the gold standard.Level of agreement 100 %. CONCLUSION : The developed SODA competence standards define diagnostic performance thresholds in relation to clinical consequences, for training and for use when auditing the optical diagnosis of diminutive colorectal polyps. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
59. Intestinal chemosensitivity in irritable bowel syndrome associates with small intestinal TRPV channel expression.
- Author
-
Grover, Madhusudan, Berumen, Antonio, Peters, Stephanie, Wei, Ting, Breen‐Lyles, Margaret, Harmsen, William S., Busciglio, Irene, Burton, Duane, Vazquez Roque, Maria, DeVault, Kenneth R., Camilleri, Michael, Wallace, Michael, Dasari, Surendra, Neumann, Helmut, and Houghton, Lesley A.
- Subjects
- *
IRRITABLE colon , *INTESTINES , *SMALL intestine , *ABDOMINAL pain , *SYMPTOMS , *PAIN threshold - Abstract
Summary: Background: Irritable bowel syndrome (IBS) patients often experience meal‐associated symptoms. However, the underlying mechanisms are unclear. Aim: To determine small intestinal mechanisms of lipid‐induced symptoms and rectal hypersensitivity in IBS Methods: We recruited 26 IBS patients (12 IBS‐C, 14 IBS‐D) and 15 healthy volunteers (HV). In vivo permeability was assessed using saccharide excretion assay. Rectal sensitivity was assessed using a barostat before and after small bowel lipid infusion; symptoms were assessed throughout. Next, an extended upper endoscopy with probe‐based confocal laser endomicroscopy (pCLE) was performed with changes induced by lipids. Duodenal and jejunal mucosal biopsies were obtained for transcriptomics. Results: Following lipid infusion, a higher proportion of HV than IBS patients reported no pain, no nausea, no fullness and no urgency (P < 0.05 for all). In a model adjusted for sex and anxiety, IBS‐C and IBS‐D patients had lower thresholds for first rectal sensation (P = 0.0007) and pain (P = 0.004) than HV. In vivo small intestinal permeability and mean pCLE scores were similar between IBS patients and HV. Post‐lipid, pCLE scores were higher than pre‐lipid but were not different between groups. Baseline duodenal transient receptor potential vanilloid (TRPV) 1 and 3 expression was increased in IBS‐D, and TRPV3 in IBS‐C. Duodenal TRPV1 expression correlated with abdominal pain (r = 0.51, FDR = 0.01), and inversely with first rectal sensation (r = −0.48, FDR = 0.01) and pain (r = −0.41, FDR = 0.02) thresholds. Conclusion: Lipid infusion elicits a greater symptom response in IBS patients than HV, which is associated with small intestinal expression of TRPV channels. TRPV‐mediated small intestinal chemosensitivity may mediate post‐meal symptoms in IBS. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
60. Barrett's esophagus. Practical issues for daily routine diagnosis
- Author
-
Vieth, Michael, Langner, Cord, Neumann, Helmut, and Takubo, Kaiyo
- Subjects
- *
BARRETT'S esophagus , *PRECANCEROUS conditions , *EXFOLIATIVE cytology , *METAPLASIA , *ADENOCARCINOMA , *ENDOSCOPIC surgery , *DIAGNOSIS - Abstract
Abstract: Most clinicians and researchers agree that Barrett''s esophagus (BE) is a precancerous condition which, however, is not easily defined. Whether goblet cells must be present or not is a matter of debate and definitions vary worldwide. Although the use of the term “columnar metaplasia” tends to circumvent these issues, it can also be subdivided into those with and without goblet cells. There is some evidence that Barrett''s esophagus results from a multistep process in which goblet cells are a secondary event. Hence, Barrett''s adenocarcinoma has recently been shown to originate from areas lacking goblet cells. The histological diagnosis of neoplasia is often hampered by marked interobserver variation. New endoscopic techniques allow for local resections of neoplasia with curative intent. Pathologists should know which pieces of information gastroenterologists need for management options: surveillance versus therapy such as endoscopic resection with or endoscopic ablation without histological specimen. The most important information for gastroenterologists is whether there is neoplasia or not; if any, they need to know the grade (low grade, high grade, carcinoma) and risk factors (vessel permeation, poor differentiation, resection complete in case of endoscopic resection, depth of infiltration). [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
61. An investigation of the diagnostic, predictive, and prognostic impacts of three colonic biopsy grading systems for acute graft versus host disease.
- Author
-
Kreft, Andreas, Hippe, Katrin, Wagner-Drouet, Eva Maria, Ries, Isabelle, Kandulski, Arne, Büttner-Herold, Maike, Neumann, Helmut, Weber, Daniela, Holler, Ernst, and Schindeldecker, Mario
- Subjects
- *
GRAFT versus host disease , *HEMATOPOIETIC stem cell transplantation , *SURVIVAL rate , *TREATMENT failure , *SYMPTOMS - Abstract
Acute graft versus host disease (aGvHD) is an important, life-threatening complication after allogeneic hematopoietic stem cell transplantation (alloHSCT). To investigate the value of multiple simultaneous colon biopsies in improving diagnostic accuracy in patients with aGvHD, we retrospectively analyzed 157 patients after alloHSCT. The biopsies were evaluated individually using three established histological grading systems (Lerner, Sale, and Melson). The maximum, minimum, median, and mean histological aGvHD grades were calculated for each patient, and the results were correlated with the Glucksberg grade of clinical manifestation of GvHD, steroid therapy status, and outcome. We found that multiple colon biopsies enhanced diagnostic sensitivity. Moreover, higher histological grades correlated with steroid therapy initiation and refractoriness; the latter particularly occurred when advanced damage was present in all samples and healthy colon mucosa was reduced or absent. On multivariate analysis, the minimal Lerner and Glucksberg grades for intestinal aGvHD were significantly associated with steroid treatment failure. Ninety-nine patients died. The median survival was 285 days after the biopsies were taken. Fifteen patients died from relapse of their underling disorder and 84 from other causes, mostly infection (53 patients) and GvHD (14 patients). Multivariate analysis revealed a significant association between none-relapse mortality and the mean Lerner grade, minimum Melson grade, Glucksberg organ stage, and platelet counts. Thus, we found the Lerner system to be superior to the other grading methods in most instances and histologic evaluation of multiple simultaneously obtained biopsies from the colon to result in a higher diagnostic yield, which helps plan systemic steroid treatment while predicting treatment response and outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
62. Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons.
- Author
-
Tontini, Gian Eugenio, Rimondi, Alessandro, Vernero, Marta, Neumann, Helmut, Vecchi, Maurizio, Bezzio, Cristina, and Cavallaro, Flaminia
- Subjects
- *
INFLAMMATORY bowel diseases , *ENDOSCOPY , *CROHN'S disease , *ARTIFICIAL intelligence , *CONVOLUTIONAL neural networks , *GASTROINTESTINAL hemorrhage , *INTESTINAL diseases - Abstract
Introduction: Since the advent of artificial intelligence (AI) in clinical studies, luminal gastrointestinal endoscopy has made great progress, especially in the detection and characterization of neoplastic and preneoplastic lesions. Several studies have recently shown the potential of AI-driven endoscopy for the investigation of inflammatory bowel disease (IBD). This systematic review provides an overview of the current position and future potential of AI in IBD endoscopy. Methods: A systematic search was carried out in PubMed and Scopus up to 2 December 2020 using the following search terms: artificial intelligence, machine learning, computer-aided, inflammatory bowel disease, ulcerative colitis (UC), Crohn's disease (CD). All studies on human digestive endoscopy were included. A qualitative analysis and a narrative description were performed for each selected record according to the Joanna Briggs Institute methodologies and the PRISMA statement. Results: Of 398 identified records, 18 were ultimately included. Two-thirds of these (12/18) were published in 2020 and most were cross-sectional studies (15/18). No relevant bias at the study level was reported, although the risk of publication bias across studies cannot be ruled out at this early stage. Eleven records dealt with UC, five with CD and two with both. Most of the AI systems involved convolutional neural network, random forest and deep neural network architecture. Most studies focused on capsule endoscopy readings in CD (n = 5) and on the AI-assisted assessment of mucosal activity in UC (n = 10) for automated endoscopic scoring or real-time prediction of histological disease. Discussion: AI-assisted endoscopy in IBD is a rapidly evolving research field with promising technical results and additional benefits when tested in an experimental clinical scenario. External validation studies being conducted in large and prospective cohorts in real-life clinical scenarios will help confirm the added value of AI in assessing UC mucosal activity and in CD capsule reading. Plain language summary: Artificial intelligence for inflammatory bowel disease endoscopy Artificial intelligence (AI) is a promising technology in many areas of medicine. In recent years, AI-assisted endoscopy has been introduced into several research fields, including inflammatory bowel disease (IBD) endoscopy, with promising applications that have the potential to revolutionize clinical practice and gastrointestinal endoscopy. We have performed the first systematic review of AI and its application in the field of IBD and endoscopy. A formal process of paper selection and analysis resulted in the assessment of 18 records. Most of these (12/18) were published in 2020 and were cross-sectional studies (15/18). No relevant biases were reported. All studies showed positive results concerning the novel technology evaluated, so the risk of publication bias cannot be ruled out at this early stage. Eleven records dealt with UC, five with CD and two with both. Most studies focused on capsule endoscopy reading in CD patients (n = 5) and on AI-assisted assessment of mucosal activity in UC patients (n = 10) for automated endoscopic scoring and real-time prediction of histological disease. We found that AI-assisted endoscopy in IBD is a rapidly growing research field. All studies indicated promising technical results. When tested in an experimental clinical scenario, AI-assisted endoscopy showed it could potentially improve the management of patients with IBD. Confirmatory evidence from real-life clinical scenarios should be obtained to verify the added value of AI-assisted IBD endoscopy in assessing UC mucosal activity and in CD capsule reading. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
63. Evaluation of a novel colonoscope offering flexibility adjuster – a retrospective observational study.
- Author
-
Gerges, Christian, Neumann Sr, Helmut, Ishaq, Sauid, Sivanathan, Visvakanth, Galle, Peter R., Neuhaus, Horst, and Neumann, Helmut
- Subjects
- *
COLORECTAL cancer , *PATIENT satisfaction , *SCIENTIFIC observation , *PROCTOLOGY , *VIRTUAL colonoscopy , *EARLY detection of cancer , *FECAL occult blood tests - Abstract
Background: Although colonoscopy is the gold standard for colorectal cancer screening, colonic looping may make complete colonoscopy challenging. Commonly available stiffening device colonoscopy has been described as helpful but not effective enough to prevent looping. In this context the effect on cecal intubation time and rate was described differently in various studies and in some studies had no impact on cecal intubation time at all. The aim of this study was to evaluate whether a novel colonoscope with gradual stiffness (Fujifilm EC760R-V/I- flexibility adjuster, Tokyo, Japan) using four significantly different grades of stiffness can be an alternative to established devices in terms of loop prevention, cecal intubation rate and time, adverse events, and patient/examiner satisfaction. Methods: Consecutive patients without previous colorectal surgery were analyzed retrospectively. Colonoscopy was performed with the new colonoscope and performance characteristics, including time to cecum, withdrawal time, total examination time, and patient and endoscopist satisfaction were recorded. Results: Among 180 consecutive procedures, 98.3% of examinations were complete to the cecum. The endoscopic flexibility adjuster was used in 150 of 180 cases (83.3%). Overall, the device was scored by the examiner as helpful to prevent looping in 146 of the 150 cases (97.7%). Mean cecal intubation time was 6.5 min, with 35% of examination performed in under 5 min with a mean withdrawal time of 7 min. Mean total examination time was 18 min. Patient satisfaction was rated as high in all examinations performed. Conclusion: The new flexibility adjuster colonoscope was shown to be helpful in loop prevention, allowed for fast and successful cecal intubation, and led to a high rate of patients satisfaction. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
64. Revising the European Society of Gastrointestinal Endoscopy (ESGE) research priorities: a research progress update.
- Author
-
Bhandari, Pradeep, Longcroft-Wheaton, Gaius, Libanio, Diogo, Pimentel-Nunes, Pedro, Albeniz, Eduardo, Pioche, Mathieu, Sidhu, Reena, Spada, Cristiano, Anderloni, Andrea, Repici, Alessandro, Haidry, Rehan, Barthet, Marc, Neumann, Helmut, Antonelli, Giulio, Testoni, Alberto, Ponchon, Thierry, Siersema, Peter D., Fuccio, Lorenzo, Hassan, Cesare, and Dinis-Ribeiro, Mario
- Subjects
- *
ENDOSCOPY , *LITERATURE reviews , *ENDOSCOPIC gastrointestinal surgery , *MEDICAL societies - Abstract
Background: One of the aims of the European Society of Gastrointestinal Endoscopy (ESGE) is to encourage high quality endoscopic research at a European level. In 2016, the ESGE research committee published a set of research priorities. As endoscopic research is flourishing, we aimed to review the literature and determine whether endoscopic research over the last 4 years had managed to address any of our previously published priorities.Methods: As the previously published priorities were grouped under seven different domains, a working party with at least two European experts was created for each domain to review all the priorities under that domain. A structured review form was developed to standardize the review process. The group conducted an extensive literature search relevant to each of the priorities and then graded the priorities into three categories: (1) no longer a priority (well-designed trial, incorporated in national/international guidelines or adopted in routine clinical practice); (2) remains a priority (i. e. the above criterion was not met); (3) redefine the existing priority (i. e. the priority was too vague with the research question not clearly defined).Results: The previous ESGE research priorities document published in 2016 had 26 research priorities under seven domains. Our review of these priorities has resulted in seven priorities being removed from the list, one priority being partially removed, another seven being redefined to make them more precise, with eleven priorities remaining unchanged. This is a reflection of a rapid surge in endoscopic research, resulting in 27 % of research questions having already been answered and another 27 % requiring redefinition.Conclusions: Our extensive review process has led to the removal of seven research priorities from the previous (2016) list, leaving 19 research priorities that have been redefined to make them more precise and relevant for researchers and funding bodies to target. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
65. Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons.
- Author
-
Tontini, Gian Eugenio, Rimondi, Alessandro, Vernero, Marta, Neumann, Helmut, Vecchi, Maurizio, Bezzio, Cristina, and Cavallaro, Flaminia
- Subjects
- *
INFLAMMATORY bowel diseases , *ARTIFICIAL intelligence , *CROHN'S disease , *CAPSULE endoscopy , *ENDOSCOPY , *GASTROINTESTINAL hemorrhage , *INTESTINAL diseases - Abstract
Introduction: Since the advent of artificial intelligence (AI) in clinical studies, luminal gastrointestinal endoscopy has made great progress, especially in the detection and characterization of neoplastic and preneoplastic lesions. Several studies have recently shown the potential of AI-driven endoscopy for the investigation of inflammatory bowel disease (IBD). This systematic review provides an overview of the current position and future potential of AI in IBD endoscopy. Methods: A systematic search was carried out in PubMed and Scopus up to 2 December 2020 using the following search terms: artificial intelligence, machine learning, computer-aided, inflammatory bowel disease, ulcerative colitis (UC), Crohn's disease (CD). All studies on human digestive endoscopy were included. A qualitative analysis and a narrative description were performed for each selected record according to the Joanna Briggs Institute methodologies and the PRISMA statement. Results: Of 398 identified records, 18 were ultimately included. Two-thirds of these (12/18) were published in 2020 and most were cross-sectional studies (15/18). No relevant bias at the study level was reported, although the risk of publication bias across studies cannot be ruled out at this early stage. Eleven records dealt with UC, five with CD and two with both. Most of the AI systems involved convolutional neural network, random forest and deep neural network architecture. Most studies focused on capsule endoscopy readings in CD (n = 5) and on the AI-assisted assessment of mucosal activity in UC (n = 10) for automated endoscopic scoring or real-time prediction of histological disease. Discussion: AI-assisted endoscopy in IBD is a rapidly evolving research field with promising technical results and additional benefits when tested in an experimental clinical scenario. External validation studies being conducted in large and prospective cohorts in real-life clinical scenarios will help confirm the added value of AI in assessing UC mucosal activity and in CD capsule reading. Plain language summary: Artificial intelligence for inflammatory bowel disease endoscopy Artificial intelligence (AI) is a promising technology in many areas of medicine. In recent years, AI-assisted endoscopy has been introduced into several research fields, including inflammatory bowel disease (IBD) endoscopy, with promising applications that have the potential to revolutionize clinical practice and gastrointestinal endoscopy. We have performed the first systematic review of AI and its application in the field of IBD and endoscopy. A formal process of paper selection and analysis resulted in the assessment of 18 records. Most of these (12/18) were published in 2020 and were cross-sectional studies (15/18). No relevant biases were reported. All studies showed positive results concerning the novel technology evaluated, so the risk of publication bias cannot be ruled out at this early stage. Eleven records dealt with UC, five with CD and two with both. Most studies focused on capsule endoscopy reading in CD patients (n = 5) and on AI-assisted assessment of mucosal activity in UC patients (n = 10) for automated endoscopic scoring and real-time prediction of histological disease. We found that AI-assisted endoscopy in IBD is a rapidly growing research field. All studies indicated promising technical results. When tested in an experimental clinical scenario, AI-assisted endoscopy showed it could potentially improve the management of patients with IBD. Confirmatory evidence from real-life clinical scenarios should be obtained to verify the added value of AI-assisted IBD endoscopy in assessing UC mucosal activity and in CD capsule reading. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
66. Evaluation of a novel colonoscope offering flexibility adjuster – a retrospective observational study.
- Author
-
Gerges, Christian, Neumann Sr, Helmut, Ishaq, Sauid, Sivanathan, Visvakanth, Galle, Peter R., Neuhaus, Horst, and Neumann, Helmut
- Subjects
- *
PATIENT satisfaction , *SCIENTIFIC observation , *PROCTOLOGY , *VIRTUAL colonoscopy , *COLORECTAL cancer , *EARLY detection of cancer , *FECAL occult blood tests - Abstract
Background: Although colonoscopy is the gold standard for colorectal cancer screening, colonic looping may make complete colonoscopy challenging. Commonly available stiffening device colonoscopy has been described as helpful but not effective enough to prevent looping. In this context the effect on cecal intubation time and rate was described differently in various studies and in some studies had no impact on cecal intubation time at all. The aim of this study was to evaluate whether a novel colonoscope with gradual stiffness (Fujifilm EC760R-V/I- flexibility adjuster, Tokyo, Japan) using four significantly different grades of stiffness can be an alternative to established devices in terms of loop prevention, cecal intubation rate and time, adverse events, and patient/examiner satisfaction. Methods: Consecutive patients without previous colorectal surgery were analyzed retrospectively. Colonoscopy was performed with the new colonoscope and performance characteristics, including time to cecum, withdrawal time, total examination time, and patient and endoscopist satisfaction were recorded. Results: Among 180 consecutive procedures, 98.3% of examinations were complete to the cecum. The endoscopic flexibility adjuster was used in 150 of 180 cases (83.3%). Overall, the device was scored by the examiner as helpful to prevent looping in 146 of the 150 cases (97.7%). Mean cecal intubation time was 6.5 min, with 35% of examination performed in under 5 min with a mean withdrawal time of 7 min. Mean total examination time was 18 min. Patient satisfaction was rated as high in all examinations performed. Conclusion: The new flexibility adjuster colonoscope was shown to be helpful in loop prevention, allowed for fast and successful cecal intubation, and led to a high rate of patients satisfaction. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
67. Long-term success of flexible endoscopic septal division with the stag beetle knife for Zenker's diverticulum: a tertiary center study.
- Author
-
Ishaq, Sauid, Siau, Keith, Lee, Minhong, Sultan, Haleema, Mohaghegh, Shalmani H, Kuwai, Toshio, Mulder, Chris J, and Neumann, Helmut
- Subjects
- *
DIVERTICULUM , *BEETLES , *SYMPTOMS , *DISEASE relapse , *KNIVES - Abstract
Objectives Flexible endoscopic septum division is an established treatment for Zenker's diverticulum (ZD); however, long-term outcome data are lacking. We aimed to evaluate the long-term efficacy of flexible endoscopic septal division (FESD) using the stag beetle knife for ZD and identify predictors of symptom recurrence. Methods Patients undergoing the procedure between 2013 and 2018 were prospectively enrolled. Procedures were performed by a single operator. Symptom severity pre- and postprocedure was recorded using the dysphagia, regurgitation, and complications scale. Symptom recurrence was defined as a total score > 1 after the index procedure. Time-to-event analyses were performed using Kaplan–Meier plots, with multivariable analyses performed using Cox regression models. Results Altogether, 65 patients (mean age 74.0 years, 60% male) were included. Previous stapling had been performed in 44.6% of patients. Over the mean posttreatment follow-up period of 19 months, 5.6% of the treatment naïve group and 34.5% of the recurrent group underwent repeated FESD (P = 0.003), with rates of symptom remission and improvement of 75.4% and 92.7%, respectively. Recurrence at 48 months was higher in patients with recurrent ZD (84.7%) than in treatment-naïve patients (10.7%). On multivariable analysis, recurrent disease (hazard ratio [HR] 20.8, P = 0.005) and younger age (HR 0.96/year, P = 0.047) were associated with symptom recurrence. Conclusions In patients with treatment-naïve ZD, flexible endoscopic septal division is safe and provides durable symptom remission. However, in patients with poststapling recurrence, the risk of recurrence is high and time-dependent. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
68. Molecular endoscopic imaging for the detection of Barrett's metaplasia using biodegradable inorganic nanoparticles: An ex-vivo pilot study on human tissue.
- Author
-
Ahmed, Shakil, Kreft, Andreas, Chowdhury, Ezharul Hoque, Hossain, Sultana Mehbuba, Galle, Peter R., and Neumann, Helmut
- Subjects
- *
BIODEGRADABLE nanoparticles , *BARRETT'S esophagus , *HUMAN experimentation , *PILOT projects , *SUMMATIVE tests - Abstract
Background and study aims: Despite major technical advancements, endoscopic surveillance for detecting premalignant lesions in Barrett's esophagus is challenging because of their flat appearance with only subtle morphological changes. Molecular endoscopic imaging (MEI) using nanoparticles (NPs), coupled with fluorescently labeled antibody permits visualization of disease-specific molecular alterations. The aim of this ex vivo study was to assess the diagnostic applicability of MEI with NPs to detect Barrett's metaplasia. Patients and methods: Seven patients undergoing endoscopic surveillance of known Barrett's esophagus were recruited. Freshly resected biopsy specimens were incubated with NPs coupled with FITC labeled Muc-2 antibodies and examined with MEI. Fluorescence intensity from Barrett's mucosa and control specimens were compared, followed by histological confirmation. Results: Fluorescence signals, indicating the presence of goblet cells, were noted for traditional MEI using Muc-2 antibodies in Barrett's intestinal metaplasia. Significantly stronger fluorescence signals were achieved with NPs coupled with FITC-conjugated Muc-2 antibodies. The results of MEI with NPs for the prediction of Barrett's metaplasia correlated with the final histopathological examination in all the cases. Conclusions: Highly-specific NPs detected Barrett's metaplasia more efficiently than conventional MEI in this first feasibility study. MEI was as effective as standard histopathology for identifying Muc-2 containing goblet cells for diagnosis of Barrett's metaplasia. (DRKS-ID: DRKS00017747) [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
69. Curriculum for optical diagnosis training in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.
- Author
-
Dekker, Evelien, Houwen, Britt B. S. L., Puig, Ignasi, Bustamante-Balén, Marco, Coron, Emmanuel, Dobru, Daniela E., Kuvaev, Roman, Neumann, Helmut, Johnson, Gavin, Pimentel-Nunes, Pedro, Sanders, David S., Dinis-Ribeiro, Mario, Arvanitakis, Marianna, Ponchon, Thierry, East, James E., and Bisschops, Raf
- Subjects
- *
BARRETT'S esophagus , *ENDOSCOPY , *SQUAMOUS cell carcinoma , *REQUIRED courses (Education) , *RESEARCH , *RESEARCH methodology , *CURRICULUM , *EVALUATION research , *MEDICAL cooperation , *COMPARATIVE studies , *ENDOSCOPIC gastrointestinal surgery , *ESOPHAGEAL tumors - Abstract
This manuscript represents an official Position Statement of the European Society of Gastrointestinal Endoscopy (ESGE) aiming to guide general gastroenterologists to develop and maintain skills in optical diagnosis during endoscopy. In general, this requires additional training beyond the core curriculum currently provided in each country. In this context, ESGE have developed a European core curriculum for optical diagnosis practice across Europe for high quality optical diagnosis training. 1: ESGE suggests that every endoscopist should have achieved general competence in upper and/or lower gastrointestinal (UGI/LGI) endoscopy before commencing training in optical diagnosis of the UGI/LGI tract, meaning personal experience of at least 300 UGI and/or 300 LGI endoscopies and meeting the ESGE quality measures for UGI/LGI endoscopy. ESGE suggests that every endoscopist should be able and competent to perform UGI/LGI endoscopy with high definition white light combined with virtual and/or dye-based chromoendoscopy before commencing training in optical diagnosis. 2: ESGE suggests competency in optical diagnosis can be learned by attending a validated optical diagnosis training course based on a validated classification, and self-learning with a minimum number of lesions. If no validated training course is available, optical diagnosis can only be learned by attending a non-validated onsite training course and self-learning with a minimum number of lesions. 3: ESGE suggests endoscopists are competent in optical diagnosis after meeting the pre-adoption and learning criteria, and meeting competence thresholds by assessing a minimum number of lesions prospectively during real-time endoscopy. ESGE suggests ongoing in vivo practice by endoscopists to maintain competence in optical diagnosis. If a competent endoscopist does not perform in vivo optical diagnosis on a regular basis, ESGE suggests repeating the learning and competence phases to maintain competence.Key areas of interest were optical diagnosis training in Barrett's esophagus, esophageal squamous cell carcinoma, early gastric cancer, diminutive colorectal lesions, early colorectal cancer, and neoplasia in inflammatory bowel disease. Condition-specific recommendations are provided in the main document. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
70. Reopening Endoscopy after the COVID-19 Outbreak: Indications from a High Incidence Scenario.
- Author
-
Elli, Luca, Tontini, Gian Eugenio, Scaramella, Lucia, Cantù, Paolo, Topa, Matilde, Dell'Osso, Bernardo, Muscatello, Antonio, Gori, Andrea, Neumann, Helmut, Penagini, Roberto, and Vecchi, Maurizio
- Subjects
- *
COVID-19 pandemic , *SURGICAL gloves , *MEDICAL personnel , *MEDICAL laws , *MEDICAL sciences , *COVID-19 ,ESOPHAGEAL atresia - Abstract
An editorial is presented on the dramatic viral pandemic from coronavirus 2 causing a severe acute respiratory distress syndrome infection spread rapidly worldwide. It mentions that strict triage activity should be continued to properly allocate the endoscopic timing, confirm appropriateness and consequently reduce the risk of SARS-CoV-2 spreading.
- Published
- 2020
- Full Text
- View/download PDF
71. Molecular endoscopic imaging: the future is bright.
- Author
-
Ahmed, Shakil, Galle, Peter R., and Neumann, Helmut
- Subjects
- *
GASTROINTESTINAL disease diagnosis , *CELL receptors , *COLON tumors , *DIAGNOSTIC imaging , *ENDOSCOPY , *EPIDERMAL growth factor , *INFLAMMATORY bowel diseases , *INTERNAL medicine , *MOLECULAR probes , *MOLECULAR diagnosis , *STOMACH tumors , *GASTROINTESTINAL tumors , *VASCULAR endothelial growth factors , *BARRETT'S esophagus , *ENDOSCOPIC gastrointestinal surgery ,RECTUM tumors - Abstract
The prediction and final survival rate of gastrointestinal cancers are dependent on the stage of disease. The ideal would be to detect those gastrointestinal lesions at early stage or even premalignant forms which are difficult to detect by conventional endoscopy with white light optical imaging as they show minimum or no changes in morphological characteristics and are thus left untreated. The introduction of molecular imaging has greatly changed the pattern for detecting gastrointestinal lesions from purely macroscopic structural imaging to the molecular level. It allows microscopic examination of the gastrointestinal mucosa with endoscopy after the topical or systemic application of molecular probes. In recent years, major advancements in endoscopic instruments and specific molecular probes have been achieved. This review focuses on the current status of endoscopic imaging and highlights the application of molecular imaging in gastrointestinal and hepatic disease in the context of diagnosis and therapy based on recently published literature in this field. We also discuss the challenges of molecular endoscopic imaging, its future directions and potential that could have a tremendous impact on endoscopic research and clinical practice in future. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
72. Endoscopic management of gastrointestinal motility disorders - part 2: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
- Author
-
Weusten, Bas L. A. M., Barret, Maximilien, Bredenoord, Albert J., Familiari, Pietro, Gonzalez, Jean-Michel, van Hooft, Jeanin E., Lorenzo-Zúñiga, Vicente, Louis, Hubert, Martinek, Jan, van Meer, Suzanne, Neumann, Helmut, Pohl, Daniel, Prat, Frederic, von Renteln, Daniel, Savarino, Edoardo, Sweis, Rami, Tack, Jan, Tutuian, Radu, and Ishaq, Sauid
- Subjects
- *
GASTROINTESTINAL motility disorders , *DIVERTICULUM , *PATIENT safety , *PROTON pump inhibitors , *ABDOMINAL wall , *GASTROESOPHAGEAL reflux , *GASTROINTESTINAL motility , *FUNDOPLICATION , *SURGICAL decompression , *GASTROINTESTINAL diseases , *ENDOSCOPIC gastrointestinal surgery , *LUMBAR vertebrae - Abstract
ESGE suggests flexible endoscopic treatment over open surgical treatment as first-line therapy for patients with a symptomatic Zenker's diverticulum of any size.Weak recommendation, low quality of evidence, level of agreement 100 %.ESGE recommends that emerging treatments for Zenker's diverticulum, such as Zenker's peroral endoscopic myotomy (Z-POEM) and tunneling, be considered as experimental; these treatments should be offered in a research setting only.Strong recommendation, low quality of evidence, level of agreement 100 %.ESGE recommends against the widespread clinical use of transoral incisionless fundoplication (TIF) as an alternative to proton pump inhibitor (PPI) therapy or antireflux surgery in the treatment of gastroesophageal reflux disease (GERD), because of the lack of data on the long-term outcomes, the inferiority of TIF to fundoplication, and its modest efficacy in only highly selected patients. TIF may have a role for patients with mild GERD who are not willing to take PPIs or undergo antireflux surgery.Strong recommendation, moderate quality of evidence, level of agreement 92.8 %.ESGE recommends against the use of the Medigus ultrasonic surgical endostapler (MUSE) in clinical practice because of insufficient data showing its effectiveness and safety in patients with GERD. MUSE should be used in clinical trials only.Strong recommendation, low quality evidence, level of agreement 100 %.ESGE recommends against the use of antireflux mucosectomy (ARMS) in routine clinical practice in the treatment of GERD because of the lack of data and its potential complications.Strong recommendation, low quality evidence, level of agreement 100 %.ESGE recommends endoscopic cecostomy only after conservative management with medical therapies or retrograde lavage has failed.Strong recommendation, low quality evidence, level of agreement 93.3 %.ESGE recommends fixing the cecum to the abdominal wall at three points (using T-anchors, a double-needle suturing device, or laparoscopic fixation) to prevent leaks and infectious adverse events, whatever percutaneous endoscopic cecostomy method is used.Strong recommendation, very low quality evidence, level of agreement 86.7 %.ESGE recommends considering endoscopic decompression of the colon in patients with Ogilvie's syndrome that is not improving with conservative treatment.Strong recommendation, low quality evidence, level of agreement 93.8 %.ESGE recommends prompt endoscopic decompression if the cecal diameter is > 12 cm and if the Ogilvie's syndrome exists for a duration of longer than 4 - 6 days.Strong recommendation, low quality evidence, level of agreement 87.5 %. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
73. Artificial intelligence in luminal endoscopy.
- Author
-
Gulati, Shraddha, Emmanuel, Andrew, Patel, Mehul, Williams, Sophie, Haji, Amyn, Hayee, Bu'Hussain, and Neumann, Helmut
- Subjects
- *
COLITIS diagnosis , *SMALL intestine surgery , *ALGORITHMS , *ARTIFICIAL intelligence , *DIAGNOSTIC imaging , *MACHINE learning , *MEDICAL referrals , *MICROSCOPY , *ARTIFICIAL neural networks , *POLYPS , *STOMACH tumors , *GASTROINTESTINAL tumors , *ENDOSCOPIC gastrointestinal surgery , *DEEP learning ,EPITHELIAL cell tumors - Abstract
Artificial intelligence is a strong focus of interest for global health development. Diagnostic endoscopy is an attractive substrate for artificial intelligence with a real potential to improve patient care through standardisation of endoscopic diagnosis and to serve as an adjunct to enhanced imaging diagnosis. The possibility to amass large data to refine algorithms makes adoption of artificial intelligence into global practice a potential reality. Initial studies in luminal endoscopy involve machine learning and are retrospective. Improvement in diagnostic performance is appreciable through the adoption of deep learning. Research foci in the upper gastrointestinal tract include the diagnosis of neoplasia, including Barrett's, squamous cell and gastric where prospective and real-time artificial intelligence studies have been completed demonstrating a benefit of artificial intelligence–augmented endoscopy. Deep learning applied to small bowel capsule endoscopy also appears to enhance pathology detection and reduce capsule reading time. Prospective evaluation including the first randomised trial has been performed in the colon, demonstrating improved polyp and adenoma detection rates; however, these appear to be relevant to small polyps. There are potential additional roles of artificial intelligence relevant to improving the quality of endoscopic examinations, training and triaging of referrals. Further large-scale, multicentre and cross-platform validation studies are required for the robust incorporation of artificial intelligence–augmented diagnostic luminal endoscopy into our routine clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
74. Endoscopic management of gastrointestinal motility disorders - part 1: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
- Author
-
Weusten, Bas L. A. M., Barret, Maximilien, Bredenoord, Albert J., Familiari, Pietro, Gonzalez, Jan-Michel, van Hooft, Jeanin E., Ishaq, Sauid, Lorenzo-Zúñiga, Vicente, Louis, Hubert, van Meer, Suzanne, Neumann, Helmut, Pohl, Daniel, Prat, Frederic, von Renteln, Daniel, Savarino, Edoardo, Sweis, Rami, Tack, Jan, Tutuian, Radu, and Martinek, Jan
- Subjects
- *
GASTROINTESTINAL motility disorders , *PYLORUS , *ESOPHAGEAL motility disorders , *BOTULINUM toxin , *ESOPHAGOGASTRIC junction , *GASTRIC emptying , *ESOPHAGUS , *GASTROINTESTINAL motility , *GASTROINTESTINAL diseases , *ENDOSCOPIC gastrointestinal surgery , *ESOPHAGEAL achalasia - Abstract
ESGE recommends the use of a graded pneumatic dilation protocol in achalasia, starting with a 30-mm dilation and followed by a 35-mm dilation at a planned interval of 2 - 4 weeks, with a subsequent 40-mm dilation when there is insufficient relief, over both a single balloon dilation procedure or the use of a larger balloon from the outset.Strong recommendation, high quality of evidence, level of agreement 100 %.ESGE recommends being cautious in treating spastic motility disorders other than achalasia with peroral endoscopic myotomy (POEM).Strong recommendation, very low quality of evidence, level of agreement 87.5 %.ESGE recommends against the routine use of botulinum toxin injections to treat patients with non-achalasia hypercontractile esophageal motility disorders (Jackhammer esophagus, distal esophageal spasm). However, if, in individual patients, endoscopic injection of botulinum toxin is chosen, ESGE recommends performing injections into four quadrants of the lower esophageal sphincter and in the lower third of the esophagus.Strong recommendation, low quality of evidence, level of agreement 78.6 %.ESGE recommends that endoscopic pylorus-directed therapy should be considered only in patients with symptoms suggestive of gastroparesis in combination with objective proof of delayed gastric emptying using a validated test, and only when medical therapy has failed.Strong recommendation, very low quality of evidence, level of agreement 100 %.ESGE recommends against the use of botulinum toxin injection in the treatment of unselected patients with gastroparesis. Strong recommendation, high quality of evidence, level of agreement 92.9 %.ESGE recommends consideration of gastric peroral endoscopic myotomy (G-POEM) in carefully selected patients only, because it is an emerging procedure with limited data on effectiveness, safety, and durability. G-POEM should be performed in expert centers only, preferably in the context of a clinical trial.Strong recommendation, low quality of evidence, level of agreement 100 %. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
75. The future of endoscopy: Advances in endoscopic image innovations.
- Author
-
Gulati, Shraddha, Patel, Mehul, Emmanuel, Andrew, Haji, Amyn, Hayee, Bu'Hussain, and Neumann, Helmut
- Subjects
- *
THREE-dimensional imaging , *ROBOTICS , *TECHNOLOGICAL innovations , *IMAGE , *ARTIFICIAL intelligence , *THREE-dimensional display systems , *MEDICAL robotics - Abstract
The latest state of the art technological innovations have led to a palpable progression in endoscopic imaging and may facilitate standardisation of practice. One of the most rapidly evolving modalities is artificial intelligence with recent studies providing real‐time diagnoses and encouraging results in the first randomised trials to conventional endoscopic imaging. Advances in functional hypoxia imaging offer novel opportunities to be used to detect neoplasia and the assessment of colitis. Three‐dimensional volumetric imaging provides spatial information and has shown promise in the increased detection of small polyps. Studies to date of self‐propelling colonoscopes demonstrate an increased caecal intubation rate and possibly offer patients a more comfortable procedure. Further development in robotic technology has introduced ex vivo automated locomotor upper gastrointestinal and small bowel capsule devices. Eye‐tracking has the potential to revolutionise endoscopic training through the identification of differences in experts and non‐expert endoscopist as trainable parameters. In this review, we discuss the latest innovations of all these technologies and provide perspective into the exciting future of diagnostic luminal endoscopy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
76. Predictive rules for optical diagnosis of < 10-mm colorectal polyps based on a dedicated software.
- Author
-
Hassan, Cesare, Bisschops, Raf, Bhandari, Pradeep, Coron, Emmanuel, Neumann, Helmut, Pech, Oliver, Correale, Loredana, and Repici, Alessandro
- Subjects
- *
COLON polyps , *LOGISTIC regression analysis , *CONFIDENCE intervals , *HISTOLOGY , *COMPUTER software , *RESEARCH , *COLONOSCOPY , *RESEARCH methodology , *EVALUATION research , *MEDICAL cooperation , *COLORECTAL cancer , *DIAGNOSTIC imaging , *COMPARATIVE studies , *ADENOMATOUS polyps - Abstract
Background: The BASIC classification for predicting in vivo colorectal polyp histology incorporates both surface and pit/vessel descriptor domains. This study aimed to define new BASIC classes for adenomatous and hyperplastic polyps.Methods: A video library (102 still images/videos of < 10-mm polyps using white-light [WLI] and blue-light imaging [BLI]) was reviewed by seven expert endoscopists. Polyps were rated according to the individual descriptors of the three BASIC domains (surface/pit/vessel). A model to predict polyp histology (adenomatous or hyperplastic) was developed using multivariable logistic regression and subsequent "leave-one-out" cross-validation. New BASIC rules were then defined by Delphi agreement. The overall accuracy of these rules when used by experts was evaluated according to the level of confidence and light type.Results: The strength of prediction for adenomatous histology from 2175 observations assessed by area under the curve (AUC; 95 % confidence interval) was poor-to-fair for the surface descriptors (0.50 [0.33 - 0.69] for mucus; 0.68 [0.57 - 0.79] for irregular surface), but stronger for pits (0.87 [0.80 - 0.96] for featureless/round/not round) and vessels (0.80 [0.65 - 0.87] for not present/lacy/pericryptal). By combining the domains, a good-to-excellent prediction was shown (AUC 0.89 [0.81 - 0.96]). After the definition of new BASIC rules for adenomatous and hyperplastic polyps, accuracy for high confidence BLI predictions was 90.3 % (86.3 % - 93.2 %), which was superior to high confidence WLI (83.7 % [77.3 % - 87.7 %]) and low confidence BLI predictions (77.7 % [61.1 % - 88.6 %]).Conclusions: Based on the strength of prediction, the new BASIC classes for adenomatous and hyperplastic histology show favorable results for accuracy and confidence levels. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
77. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2019.
- Author
-
Bisschops, Raf, East, James E., Hassan, Cesare, Hazewinkel, Yark, Kamiński, Michał F., Neumann, Helmut, Pellisé, Maria, Antonelli, Giulio, Bustamante Balen, Marco, Coron, Emmanuel, Cortas, Georges, Iacucci, Marietta, Yuichi, Mori, Longcroft-Wheaton, Gaius, Pilonis, Nastazja, Puig, Ignasi, van Hooft, Jeanin E., Dekker, Evelien, and Mouzyka, Serguei
- Subjects
- *
COLON polyps , *HEREDITARY nonpolyposis colorectal cancer , *ENDOSCOPY , *ADENOMATOUS polyps , *ARTIFICIAL intelligence , *COLITIS - Abstract
1: ESGE suggests that high definition endoscopy, and dye or virtual chromoendoscopy, as well as add-on devices, can be used in average risk patients to increase the endoscopist's adenoma detection rate. However, their routine use must be balanced against costs and practical considerations.Weak recommendation, high quality evidence. 2: ESGE recommends the routine use of high definition systems in individuals with Lynch syndrome.Strong recommendation, high quality evidence. 3: ESGE recommends the routine use, with targeted biopsies, of dye-based pancolonic chromoendoscopy or virtual chromoendoscopy for neoplasia surveillance in patients with long-standing colitis.Strong recommendation, moderate quality evidence. 4: ESGE suggests that virtual chromoendoscopy and dye-based chromoendoscopy can be used, under strictly controlled conditions, for real-time optical diagnosis of diminutive (≤ 5 mm) colorectal polyps and can replace histopathological diagnosis. The optical diagnosis has to be reported using validated scales, must be adequately photodocumented, and can be performed only by experienced endoscopists who are adequately trained, as defined in the ESGE curriculum, and audited.Weak recommendation, high quality evidence. 5: ESGE recommends the use of high definition white-light endoscopy in combination with (virtual) chromoendoscopy to predict the presence and depth of any submucosal invasion in nonpedunculated colorectal polyps prior to any treatment. Strong recommendation, moderate quality evidence. 6: ESGE recommends the use of virtual or dye-based chromoendoscopy in addition to white-light endoscopy for the detection of residual neoplasia at a piecemeal polypectomy scar site. Strong recommendation, moderate quality evidence. 7: ESGE suggests the possible incorporation of computer-aided diagnosis (detection and characterization of lesions) to colonoscopy, if acceptable and reproducible accuracy for colorectal neoplasia is demonstrated in high quality multicenter in vivo clinical studies. Possible significant risks with implementation, specifically endoscopist deskilling and over-reliance on artificial intelligence, unrepresentative training datasets, and hacking, need to be considered. Weak recommendation, low quality evidence. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
78. Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
- Author
-
van Leerdam, Monique E., Roos, Victorine H., van Hooft, Jeanin E., Balaguer, Francesc, Dekker, Evelien, Kaminski, Michal F., Latchford, Andrew, Neumann, Helmut, Ricciardiello, Luigi, Rupińska, Maria, Saurin, Jean-Christophe, Tanis, Pieter J., Wagner, Anja, Jover, Rodrigo, and Pellisé, Maria
- Abstract
ESGE recommends that individuals with Lynch syndrome should be followed in dedicated units that practice monitoring of compliance and endoscopic performance measures.Strong recommendation, low quality evidence, level of agreement 100 %.ESGE recommends starting colonoscopy surveillance at the age of 25 years for MLH1 and MSH2 mutation carriers and at the age of 35 years for MSH6 and PMS2 mutation carriers.Strong recommendation, moderate quality evidence, level of agreement 100 %. ESGE recommends the routine use of high-definition endoscopy systems in individuals with Lynch syndrome. Strong recommendation, high quality evidence, level of agreement 100 %. ESGE suggests the use of chromoendoscopy may be of benefit in individuals with Lynch syndrome undergoing colonoscopy; however routine use must be balanced against costs, training, and practical considerations.Weak recommendation, moderate quality evidence, level of agreement 89 %.ESGE recommends definition of familial risk of colorectal cancer as the presence of at least two first-degree relatives with colorectal cancer or at least one first-degree relative with colorectal cancer before the age of 50 years.Strong recommendation, moderate quality evidence, level of agreement 92 %.ESGE recommends colonoscopy surveillance in first-degree relatives of colorectal cancer patients in families that fulfill the definition of familial risk of colorectal cancer.Strong recommendation, moderate quality evidence, level of agreement 100 %. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
79. Endoscopic ultrasonography and small‐bowel endoscopy: Present and future.
- Author
-
Tontini, Gian Eugenio, Manfredi, Guido, Orlando, Stefania, Neumann, Helmut, Vecchi, Maurizio, Buscarini, Elisabetta, and Elli, Luca
- Subjects
- *
ENDOSCOPIC ultrasonography , *CAPSULE endoscopy , *ENDOSCOPY , *ENTEROSCOPY , *TECHNOLOGICAL innovations - Abstract
Over the last decade, impressive technological advances have occurred in ultrasonography and small‐bowel endoscopy. Nowadays, endoscopic ultrasonography is an essential diagnostic tool and a therapeutic weapon for pancreatobiliary disorders. Capsule endoscopy and device‐assisted enteroscopy have quickly become the reference standard for the diagnosis of small‐bowel luminal diseases, thereby leading to radical changes in diagnostic and therapeutic pathways. We herein provide an up‐to‐date overview of the latest advances in endoscopic ultrasonography and small‐bowel endoscopy, focusing on the emerging paradigms and technological innovations that might improve clinical practice in the near future. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
80. Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
- Author
-
van Leerdam, Monique E., Roos, Victorine H., van Hooft, Jeanin E., Dekker, Evelien, Jover, Rodrigo, Kaminski, Michal F., Latchford, Andrew, Neumann, Helmut, Pellisé, Maria, Saurin, Jean-Christophe, Tanis, Pieter J., Wagner, Anja, Balaguer, Francesc, and Ricciardiello, Luigi
- Subjects
- *
ENDOSCOPY , *SYNDROMES , *DIGESTIVE system endoscopic surgery , *GUIDELINES , *COLONOSCOPY - Abstract
ESGE recommends that individuals with hereditary gastrointestinal polyposis syndromes should be surveilled in dedicated units that provide monitoring of compliance and endoscopic performance measures. Strong recommendation, moderate quality of evidence, level of agreement 90 %.ESGE recommends performing esophagogastroduodenoscopy, small-bowel examination, and/or colonoscopy earlier than the planned surveillance procedure if a patient is symptomatic. Strong recommendation, low quality of evidence, level of agreement 100 %. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
81. Esophageal post-inflammatory polyposis in extensive and severe Crohn's disease treated with anti-tumor necrosis factor alpha.
- Author
-
Soriani, Paola, Tontini, Gian Eugenio, Neumann, Helmut, Ishaq, Sauid, Annunziata, Maria Laura, Pastorelli, Luca, and Vecchi, Maurizio
- Subjects
- *
CROHN'S disease , *INFLAMMATORY bowel disease treatment , *TUMOR necrosis factors , *DEGLUTITION disorders , *PATIENTS , *THERAPEUTICS , *ESOPHAGUS diseases , *POLYPS , *SEVERITY of illness index , *ENDOSCOPIC gastrointestinal surgery , *CHEMICAL inhibitors , *DISEASE complications - Abstract
The article presents a case study of a 69-year-old man with a history of crohn's disease who presented to hospital department with diarrhea, weight loss and dysphagia. It mentions that Ileocolonoscopy and cross-sectional imaging of the patient showed severe and extensive inflammatory lesions with diagnosis of Crohn's disease. It informs that anti-tumor necrosis factor alpha therapy was used for treatment of esophageal post-inflammatory polyposis in extensive and severe crohn's disease.
- Published
- 2016
- Full Text
- View/download PDF
82. Molecular endoscopic imaging in cancer.
- Author
-
Ahmed, Shakil, Strand, Susanne, Weinmann‐Menke, Julia, Urbansky, Lana, Galle, Peter R., and Neumann, Helmut
- Subjects
- *
CANCER risk factors , *CANCER diagnosis , *CANCER treatment , *BIOLOGICAL tags , *GASTROINTESTINAL diseases , *INDIVIDUALIZED medicine , *DISEASE progression - Abstract
Cancer is one of the major causes of death in both the USA and Europe. Molecular imaging is a novel field that is revolutionizing cancer management. It is based on the molecular signature of cells in order to study the human body both in normal and diseased conditions. The emergence of molecular imaging has been driven by the difficulties associated with cancer detection, particularly early‐stage premalignant lesions which are often unnoticed as a result of minimal or no structural changes. Endoscopic surveillance is the standard method for early‐stage cancer detection. In addition to recent major advancements in endoscopic instruments, significant progress has been achieved in the exploration of highly specific molecular probes and the combination of both will permit significant improvement of patient care. In this review, we provide an outline of the current status of endoscopic imaging and focus on recent applications of molecular imaging in gastrointestinal, hepatic and other cancers in the context of detection, targeted therapy and personalized medicine. As new imaging agents have the potential to broadly expand our cancer diagnostic capability, we will also present an overview of the main types of optical molecular probes with their pros and cons. We conclude by discussing the challenges and future prospects of the field. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
83. Development and validation of the SIMPLE endoscopic classification of diminutive and small colorectal polyps.
- Author
-
Iacucci, Marietta, Trovato, Cristina, Daperno, Marco, Akinola, Oluseyi, Greenwald, David, Gross, Seth A., Hoffman, Arthur, Lee, Jeffrey, Lethebe, Brendan C., Lowerison, Mark, Nayor, Jennifer, Neumann, Helmut, Rath, Timo, Sanduleanu, Silvia, Sharma, Prateek, Kiesslich, Ralf, Ghosh, Subrata, Saltzman, John R., and the SIMPLE classification investigator team, and SIMPLE classification investigator team
- Subjects
- *
COLON polyps , *ENDOSCOPY , *NOSOLOGY , *THERAPEUTICS , *ADENOMA , *ANTHROPOMETRY , *COLON tumors , *COLONOSCOPY , *COMPARATIVE studies , *CONSENSUS (Social sciences) , *DELPHI method , *DIAGNOSTIC imaging , *INTERNAL medicine , *RESEARCH methodology , *MEDICAL cooperation , *RESEARCH , *RESEARCH funding , *EVALUATION research , *PREDICTIVE tests , *RESEARCH bias ,RECTUM tumors ,RESEARCH evaluation - Abstract
Background: Prediction of histology of small polyps facilitates colonoscopic treatment. The aims of this study were: 1) to develop a simplified polyp classification, 2) to evaluate its performance in predicting polyp histology, and 3) to evaluate the reproducibility of the classification by trainees using multiplatform endoscopic systems.Methods: In phase 1, a new simplified endoscopic classification for polyps - Simplified Identification Method for Polyp Labeling during Endoscopy (SIMPLE) - was created, using the new I-SCAN OE system (Pentax, Tokyo, Japan), by eight international experts. In phase 2, the accuracy, level of confidence, and interobserver agreement to predict polyp histology before and after training, and univariable/multivariable analysis of the endoscopic features, were performed. In phase 3, the reproducibility of SIMPLE by trainees using different endoscopy platforms was evaluated.Results: Using the SIMPLE classification, the accuracy of experts in predicting polyps was 83 % (95 % confidence interval [CI] 77 % - 88 %) before and 94 % (95 %CI 89 % - 97 %) after training (P = 0.002). The sensitivity, specificity, positive predictive value, and negative predictive value after training were 97 %, 88 %, 95 %, and 91 %. The interobserver agreement of polyp diagnosis improved from 0.46 (95 %CI 0.30 - 0.64) before to 0.66 (95 %CI 0.48 - 0.82) after training. The trainees demonstrated that the SIMPLE classification is applicable across endoscopy platforms, with similar post-training accuracies for narrow-band imaging NBI classification (0.69; 95 %CI 0.64 - 0.73) and SIMPLE (0.71; 95 %CI 0.67 - 0.75).Conclusions: Using the I-SCAN OE system, the new SIMPLE classification demonstrated a high degree of accuracy for adenoma diagnosis, meeting the ASGE PIVI recommendations. We demonstrated that SIMPLE may be used with either I-SCAN OE or NBI. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
84. New and emerging techniques for endoscopic treatment of Zenker's diverticulum: State‐of‐the‐art review.
- Author
-
Ishaq, Sauid, Sultan, Haleema, Siau, Keith, Kuwai, Toshio, Mulder, Chris J., and Neumann, Helmut
- Subjects
- *
PHARYNGEAL diseases , *DIVERTICULUM , *HERNIA treatment , *DEGLUTITION disorders , *ENDOSCOPIC surgery , *ARGON plasmas , *THERAPEUTICS - Abstract
Zenker's diverticulum (ZD), or pharyngeal pouch, is an anatomical defect characterized by herniation of the posterior pharyngeal wall through Killian's dehiscence, and may result in dysphagia and regurgitation. Multiple therapeutic modalities including surgery, rigid and flexible endoscopy have been developed to manage ZD. Although surgical management with open and endoscopically assisted techniques have historically been the mainstay of ZD treatment, minimally invasive flexible endoscopic techniques, carried out under conscious sedation, are increasingly favored. Over the last two decades, the advent of new accessories and techniques have changed the landscape of endotherapy for ZD, with the current armamentarium including, but not limited to, endoscopic stapling, CO2 laser, argon plasma coagulation, needle knife, bipolar forceps, hook knife, clutch cutter, stag beetle knife, and submucosal tunneling endoscopic septum division. We hereby review the latest evidence to support the endoscopic management of ZD. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
85. Advanced endoscopic imaging for diagnosis of inflammatory bowel diseases: Present and future perspectives.
- Author
-
Sivanathan, Visvakanth, Tontini, Gian Eugenio, Möhler, Markus, Galle, Peter R., and Neumann, Helmut
- Subjects
- *
INFLAMMATORY bowel disease diagnosis , *CROHN'S disease diagnosis , *ULCERATIVE colitis diagnosis , *ENDOSCOPY , *DIFFERENTIAL diagnosis - Abstract
Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases (IBD) causing severe damage of the luminal gastrointestinal tract. Differential diagnosis between both disease entities is sometimes awkward requiring a multifactorial pathway, including clinical and laboratory data, radiological findings, histopathology and endoscopy. Apart from disease diagnosis, endoscopy in IBD plays a major role in prediction of disease severity and extent (i.e. mucosal healing) for tailored patient management and for screening of colitis‐associated cancer and its precursor lesions. In this state‐of‐the‐art review, we focus on current applications of endoscopy for diagnosis and surveillance of IBD. Moreover, we will discuss the latest guidelines on surveillance and provide an overview of the most recent developments in the field of endoscopic imaging and IBD. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
86. BASIC (BLI Adenoma Serrated International Classification) classification for colorectal polyp characterization with blue light imaging.
- Author
-
Bisschops, Raf, Hassan, Cesare, Bhandari, Pradeep, Coron, Emmanuel, Neumann, Helmut, Pech, Oliver, Correale, Loredana, and Repici, Alessandro
- Subjects
- *
ADENOMATOUS polyps , *COLONOSCOPY , *PRECANCEROUS conditions - Abstract
Background and Study Aim: Advanced endoscopic imaging has revolutionized the characterization of lesions during colonoscopy. The aim of this study was to create a new classification for differentiating subcentimetric hyperplastic and adenomatous polyps, and deeply invasive malignant lesions using blue-light imaging (BLI) with high definition, with and without optical magnification, as well as to assess its interobserver concordance.Methods: A video library consisting of 48 videos/still images (with/without optical magnification) from 24 histologically verified polyps/cancer with BLI was prospectively created. In the first step, seven endoscopists with experience in electronic chromoendoscopy reviewed 12 BLI videos/still images with/without magnification representative of the different histotypes, and individually identified possible descriptors. In the second step, these descriptors were categorized and summarized with a modified Delphi methodology. In the third step, the seven endoscopists independently reviewed the remaining 36 videos/still images with/without optical magnification, and the interobserver agreement for the new descriptors was assessed. The interobserver agreement between endoscopists was assessed using Gwet's AC1.Results: By reviewing the initial 12 videos/still images, 43 descriptors were proposed. By a modified Delphi process, the endoscopists eventually agreed on summarizing 12 descriptors into three main domains. The main domains identified were: polyp surface (mucus, yes/no; regular/irregular; [pseudo]depressed, yes/no), pit appearance (featureless, yes/no; round/nonround with/without dark spots; homogeneous/heterogeneous distribution with/without focal loss), and vessels (present/absent, lacy, pericryptal, irregular). Interobserver agreement for the polyp surface domain appeared to be almost perfect for mucus (AC1 0.92 with and 0.88 without optical magnification), substantial for the regular/irregular surface (AC1 0.67 with and 0.66 without optical magnification). For the pit appearance domain, interobserver agreement was good for featureless (AC1 0.9 with and 0.8 without optical magnification), and round/nonround (AC1 0.77 with and 0.69 without optical magnification) descriptors, but less consistent for the homogeneity of distribution (AC1 with/without optical magnification 0.58). Agreement was almost perfect for the vessel domain (AC1 0.81 - 0.85).Conclusions: The new BASIC classification takes into account both morphological features of the polyp, as well as crypt and vessel characteristics. A high concordance among the observers was shown for most of the summarized descriptors. Optical magnification had a beneficial effect in terms of interobserver agreement for most of the descriptors. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
87. Endoscopic full-thickness resection for diagnosis of Hirschsprung's disease.
- Author
-
Martínez-Alcalá, Alvaro, García, Felipe Martínez-Alcalá, Mönkemülle, Klaus, Neumann, Helmut, Martínez-Alcalá, Felipe, Martínez-Alcalá García, Felipe, and Mönkemüller, Klaus
- Subjects
- *
HIRSCHSPRUNG'S disease , *ENDOSCOPY , *CHRONIC diseases , *CONSTIPATION , *SURGICAL diagnosis , *DISEASE complications , *ENDOSCOPIC gastrointestinal surgery , *EQUIPMENT & supplies - Abstract
The article presents a case study of a 19-year-old woman with chronic constipation, who was diagnosed with Hirschsprung's disease using endoscopic full-thickness resection (EFTR).
- Published
- 2018
- Full Text
- View/download PDF
88. Editorial: understanding IBS pathophysiology through "converging channels" of research—authors' reply.
- Author
-
Grover, Madhusudan, Berumen, Antonio, Peters, Stephanie, Wei, Ting, Breen‐Lyles, Margaret, Harmsen, William S., Busciglio, Irene, Burton, Duane, Vazquez Roque, Maria, DeVault, Kenneth R., Camilleri, Michael, Wallace, Michael, Dasari, Surendra, Neumann, Helmut, and Houghton, Lesley A.
- Subjects
- *
PATHOLOGICAL physiology , *AUTHORS - Abstract
LINKED CONTENT: This article is linked to Grover et al and Elwing & Sayuk papers. To view these articles, visit https://doi.org/10.1111/apt.16591 and https://doi.org/10.1111/apt.16603 [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
89. Development and validation of a classification and scoring system for the diagnosis of oral squamous cell carcinomas through confocal laser endomicroscopy.
- Author
-
Oetter, Nicolai, Knipfer, Christian, Rohde, Maximilian, von Wilmowsky, Cornelius, Maier, Andreas, Brunner, Kathrin, Adler, Werner, Neukam, Friedrich-Wilhelm, Neumann, Helmut, and Stelzle, Florian
- Subjects
- *
SQUAMOUS cell carcinoma , *ORAL cancer diagnosis , *HISTOLOGY , *MICROSCOPY , *BIOPSY , *DIAGNOSIS , *MOUTH tumors , *THREE-dimensional imaging ,CANCER diagnostic equipment ,RESEARCH evaluation - Abstract
Background: Confocal laser endomicroscopy (CLE) is an optical biopsy method allowing in vivo microscopic imaging at 1000-fold magnification. It was the aim to evaluate CLE in the human oral cavity for the differentiation of physiological/carcinomatous mucosa and to establish and validate, for the first time, a scoring system to facilitate CLE assessment.Methods: The study consisted of 4 phases: (1) CLE-imaging (in vivo) was performed after the intravenous injection of fluorescein in patients with histologically confirmed carcinomatous oral mucosa; (2) CLE-experts (n = 3) verified the applicability of CLE in the oral cavity for the differentiation between physiological and cancerous tissue compared to the gold standard of histopathological assessment; (3) based on specific patterns of tissue changes, CLE-experts (n = 3) developed a classification and scoring system (DOC-Score) to simplify the diagnosis of oral squamous cell carcinomas; (4) validation of the newly developed DOC-Score by non-CLE-experts (n = 3); final statistical evaluation of their classification performance (comparison to the results of CLE-experts and the histopathological analyses).Results: Experts acquired and edited 45 sequences (260 s) of physiological and 50 sequences (518 s) of carcinomatous mucosa (total: 95 sequences/778 s). All sequences were evaluated independently by experts and non-experts (based on the newly proposed classification system). Sensitivity (0.953) and specificity (0.889) of the diagnoses by experts as well as sensitivity (0.973) and specificity (0.881) of the non-expert ratings correlated well with the results of the present gold standard of tissue histopathology. Experts had a positive predictive value (PPV) of 0.905 and a negative predictive value (NPV) of 0.945. Non-experts reached a PPV of 0.901 and a NPV of 0.967 with the help of the DOC-Score. Inter-rater reliability (Fleiss` kappa) was 0.73 for experts and 0.814 for non-experts. The intra-rater reliability (Cronbach's alpha) of the experts was 0.989 and 0.884 for non-experts.Conclusions: CLE is a suitable and valid method for experts to diagnose oral cancer. Using the DOC-Score system, an accurate chair-side diagnosis of oral cancer is feasible with comparable results to the gold standard of histopathology-even in daily clinical practice for non-experienced raters. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
90. In vivo real-time assessment of colorectal polyp histology using an optical biopsy forceps system based on laser-induced fluorescence spectroscopy.
- Author
-
Rath, Timo, Tontini, Gian E., Vieth, Michael, Nägel, Andreas, Neurath, Markus F., and Neumann, Helmut
- Subjects
- *
COLONOSCOPY , *ADENOMA , *BIOPSY , *COLON (Anatomy) , *COLON tumors , *DIAGNOSTIC imaging , *FLUORESCENCE spectroscopy , *LASERS , *LONGITUDINAL method , *MEDICAL protocols , *RECTUM , *EQUIPMENT & supplies , *PREDICTIVE tests , *BLIND experiment , *COLON polyps ,RECTUM tumors - Abstract
Background and study aims: In order to reduce time, costs, and risks associated with resection of diminutive colorectal polyps, the American Society for Gastrointestinal Endoscopy (ASGE) recently proposed performance thresholds that new technologies should meet for the accurate real-time assessment of histology of colorectal polyps. In this study, we prospectively assessed whether laser-induced fluorescence spectroscopy (LIFS), using the new WavSTAT4 optical biopsy system, can meet the ASGE criteria. Patients and methods: 27 patients undergoing screening or surveillance colonoscopy were included. The histology of 137 diminutive colorectal polyps was predicted in real time using LIFS and findings were compared with the results of conventional histopathological examination. The accuracy of predicting polyp histology with WavSTAT4 was assessed according to the ASGE criteria. Results: The overall accuracy of LIFS using WavSTAT4 for predicting polyp histology was 84.7 % with sensitivity, specificity, and negative predictive value (NPV) of 81.8 %, 85.2 %, and 96.1 %. When only distal colorectal diminutive polyps were considered, the NPV for excluding adenomatous histology increased to 100 % (accuracy 82.4 %, sensitivity 100 %, specificity 80.6 %). On-site, LIFS correctly predicted the recommended surveillance intervals with an accuracy of 88.9 % (24/27 patients) when compared with histology-based United States guideline recommendations; in the 3 patients for whom LIFS- and histopathology-based recommended surveillance intervals differed, LIFS predicted shorter surveillance intervals. Conclusions: From the data of this pilot study, LIFS using the WavSTAT4 system appears accurate enough to allow distal colorectal polyps to be left in place and nearly reaches the threshold to “resect and discard” them without pathologic assessment. WavSTAT4 therefore has the potential to reduce costs and risks associated with the removal of diminutive colorectal polyps. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
91. IRAK-M Expression in Tumor Cells Supports Colorectal Cancer Progression through Reduction of Antimicrobial Defense and Stabilization of STAT3.
- Author
-
Kesselring, Rebecca, Glaesner, Joachim, Hiergeist, Andreas, Naschberger, Elisabeth, Neumann, Helmut, Brunner, Stefan M., Wege, Anja K., Seebauer, Caroline, Köhl, Gudrun, Merkl, Susanne, Croner, Roland S., Hackl, Christina, Stürzl, Michael, Neurath, Markus F., Gessner, André, Schlitt, Hans-Juergen, Geissler, Edward K., and Fichtner-Feigl, Stefan
- Subjects
- *
COLON cancer , *CANCER cells , *CANCER invasiveness , *GENE expression , *ANTI-infective agents , *STAT proteins - Abstract
Summary Colorectal cancer (CRC) is associated with loss of epithelial barrier integrity, which facilitates the interaction of the immunological microenvironment with the luminal microbiome, eliciting tumor-supportive inflammation. An important regulator of intestinal inflammatory responses is IRAK-M, a negative regulator of TLR signaling. Here we investigate the compartment-specific impact of IRAK-M on colorectal carcinogenesis using a mouse model. We demonstrate that IRAK-M is expressed in tumor cells due to combined TLR and Wnt activation. Tumor cell-intrinsic IRAK-M is responsible for regulation of microbial colonization of tumors and STAT3 protein stability in tumor cells, leading to tumor cell proliferation. IRAK-M expression in human CRCs is associated with poor prognosis. These results suggest that IRAK-M may be a potential therapeutic target for CRC treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
92. Development of a new classification for in vivo diagnosis of duodenal epithelial tumors with confocal laser endomicroscopy: A pilot study.
- Author
-
Nonaka, Kouichi, Ohata, Ken, Ichihara, Shin, Ban, Shinichi, Hiejima, Yoshimitsu, Minato, Yohei, Tashima, Tomoaki, Matsuyama, Yasushi, Takita, Maiko, Matsuhashi, Nobuyuki, Takasugi, Rumi, and Neumann, Helmut
- Subjects
- *
DUODENAL diseases , *TUMORS , *GASTROINTESTINAL diseases , *HISTOPATHOLOGY , *TISSUE wounds , *IMMUNOSPECIFICITY , *DIAGNOSIS - Abstract
Background and Aim Confocal laser endomicroscopy (CLE) has been established for in vivo diagnosis of various gastrointestinal diseases. However, validated criteria for confocal diagnosis of duodenal tumors do not exist. Therefore, the aim of the present pilot study was to develop a novel classification for in vivo optical diagnosis of duodenal tumors using CLE. Methods Consecutive patients with duodenal tumorous lesions were included. First, an initial classification system was developed which was then validated. Histopathology was used as a reference standard. Results A simple classification system for in vivo diagnosis of duodenal epithelial tumors using CLE was developed. Sensitivity, specificity, and accuracy were 90%, 100%, and 97%, respectively. Positive and negative predictive values were calculated as 100% and 96%. The kappa coefficient representing consistency was 1 between observers and within each observer. Conclusion A new classification for in vivo diagnosis of duodenal epithelial tumors using confocal imaging has been developed. The new classification system allows adequate prediction of histology and could therefore be used to guide subsequent therapy of duodenal lesions. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
93. High-definition endoscopy with digital chromoendoscopy for histologic prediction of distal colorectal polyps.
- Author
-
Rath, Timo, Tontini, Gian E., Nägel, Andreas, Vieth, Michael, Zopf, Steffen, Günther, Claudia, Hoffman, Arthur, Neurath, Markus F., and Neumann, Helmut
- Subjects
- *
COLON polyps , *ENDOSCOPY , *HYPERPLASIA , *ADENOMATOUS polyps , *MEDICAL screening , *CLINICAL trials , *DIAGNOSIS , *COLON tumors , *COLONOSCOPY , *DIAGNOSTIC imaging , *INTESTINAL polyps , *LONGITUDINAL method , *PUBLIC health surveillance , *PREDICTIVE tests , *ECONOMICS , *SURGERY - Abstract
Background: Distal diminutive colorectal polyps are common and accurate endoscopic prediction of hyperplastic or adenomatous polyp histology could reduce procedural time, costs and potential risks associated with the resection. Within this study we assessed whether digital chromoendoscopy can accurately predict the histology of distal diminutive colorectal polyps according to the ASGE PIVI statement.Methods: In this prospective cohort study, 224 consecutive patients undergoing screening or surveillance colonoscopy were included. Real time histology of 121 diminutive distal colorectal polyps was evaluated using high-definition endoscopy with digital chromoendoscopy and the accuracy of predicting histology with digital chromoendoscopy was assessed.Results: The overall accuracy of digital chromoendoscopy for prediction of adenomatous polyp histology was 90.1 %. Sensitivity, specificity, positive and negative predictive values were 93.3, 88.7, 88.7, and 93.2 %, respectively. In high-confidence predictions, the accuracy increased to 96.3 % while sensitivity, specificity, positive and negative predictive values were calculated as 98.1, 94.4, 94.5, and 98.1 %, respectively. Surveillance intervals with digital chromoendoscopy were correctly predicted with >90 % accuracy.Conclusions: High-definition endoscopy in combination with digital chromoendoscopy allowed real-time in vivo prediction of distal colorectal polyp histology and is accurate enough to leave distal colorectal polyps in place without resection or to resect and discard them without pathologic assessment. This approach has the potential to reduce costs and risks associated with the redundant removal of diminutive colorectal polyps.Trial Registration: ClinicalTrials NCT02217449. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
94. Confocal laser endomicroscopy for the differential diagnosis of ulcerative colitis and Crohn's disease: a pilot study.
- Author
-
Tontini, Gian Eugenio, Mudter, Jonas, Vieth, Michael, Atreya, Raja, Günther, Claudia, Zopf, Yurdagül, Wildner, Dane, Kiesslich, Ralf, Vecchi, Maurizio, Neurath, Markus F., and Neumann, Helmut
- Subjects
- *
ULCERATIVE colitis diagnosis , *CROHN'S disease diagnosis , *INFLAMMATORY bowel disease treatment , *ENDOSCOPY , *TREATMENT effectiveness - Abstract
Background and study aim: The differential diagnosis of ulcerative colitis from Crohn's disease is of pivotal importance for the management of inflammatory bowel diseases, as both entities involve specific therapeutic management strategies. Confocal laser endomicroscopy (CLE) allows on-demand, in vivo characterization of architectural and cellular details during endoscopy. The aim of this study was to assess the efficacy of CLE to differentiate between ulcerative colitis and Crohn's disease. Patients and methods: This was a prospective study involving consecutive patients with a wellestablished diagnosis of ulcerative colitis or Crohn's disease who underwent colonoscopy with fluorescein-aided confocal imaging. Results: Overall, 79 patients were included (40 Crohn's disease, 39 ulcerative colitis). CLE findings in patients with Crohn's disease, showed significantly more discontinuous inflammation (87.5% vs. 5.1 %), focal cryptitis (75.0% vs. 12.8 %), and discontinuous crypt architectural abnormality (87.5% vs. 10.3 %) than in ulcerative colitis (P<0.0001). Conversely, ulcerative colitis was associated with severe, widespread crypt distortion (87.2% vs. 17.5% in Crohn's disease), decreased crypt density (79.5% vs. 22.5 %), and frankly irregular surface (89.7% vs. 17.5 %; P<0.0001 for all comparisons). Statistically significant differences were not seen for heavy, diffuse lamina propria cell increase or mucin preservation. No granulomas were visible. Based on these findings, a CLE scoring system was developed that revealed excellent accuracy (93.7 %) when compared with the historical clinical diagnosis and the histopathological gold standard. Conclusions: CLE could visualize several disease specific microscopic features, which are conventionally used in standard histopathology to differentiate between ulcerative colitis and Crohn's disease. However, because of the limited penetration depth of CLE, submucosal details or granulomas were not visible. The new scoring system may allow in vivo diagnosis of ulcerative colitis or Crohn's disease. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
95. Caspase-8 controls the gut response to microbial challenges by Tnf-α-dependent and independent pathways.
- Author
-
Günther, Claudia, Buchen, Barbara, Gui-Wei He, Hornef, Mathias, Torow, Natalia, Neumann, Helmut, Wittkopf, Nadine, Martini, Eva, Basic, Marijana, Bleich, André, Watson, Alastair J. M., Neurath, Markus F., and Becker, Christoph
- Subjects
- *
INFLAMMATION treatment , *EPITHELIAL cells , *GUT microbiome , *CASPASE inhibitors , *TUMOR necrosis factors , *PHYSIOLOGICAL effects of lipopolysaccharides , *THERAPEUTICS - Abstract
Objectives Intestinal epithelial cells (IEC) express tolllike receptors (TLR) that facilitate microbial recognition. Stimulation of TLR ligands induces a transient increase in epithelial cell shedding, a mechanism that serves the antibacterial and antiviral host defence of the epithelium and promotes elimination of intracellular pathogens. Although activation of the extrinsic apoptosis pathway has been described during inflammatory shedding, its functional involvement is currently unclear. Design We investigated the functional involvement of caspase-8 signalling in microbial-induced intestinal cell shedding by injecting Lipopolysaccharide (LPS) to mimic bacterial pathogens and poly(I:C) as a probe for RNA viruses in vivo. Results TLR stimulation of IEC was associated with a rapid activation of caspase-8 and increased epithelial cell shedding. In mice with an epithelial cell-specific deletion of caspase-8 TLR stimulation caused Rip3-dependent epithelial necroptosis instead of apoptosis. Mortality and tissue damage were more severe in mice in which IECs died by necroptosis than apoptosis. Inhibition of receptor-interacting protein (Rip) kinases rescued the epithelium from TLR-induced gut damage. TLR3-induced necroptosis was directly mediated via TRIF-dependent pathways, independent of Tnf-a and type III interferons, whereas TLR4-induced tissue damage was critically dependent on Tnf-α. Conclusions Together, our data demonstrate an essential role for caspase-8 in maintaining the gut barrier in response to mucosal pathogens by permitting inflammatory shedding and preventing necroptosis of infected cells. These data suggest that therapeutic strategies targeting the cell death machinery represent a promising new option for the treatment of inflammatory and infective enteropathies. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
96. Prospective Long-Term Assessment of Sedation-Related Adverse Events and Patient Satisfaction for Upper Endoscopy and Colonoscopy.
- Author
-
Kilgert, Beate, Rybizki, Lydia, Grottke, Michael, Neurath, Markus F., and Neumann, Helmut
- Subjects
- *
CONSCIOUS sedation , *ENDOSCOPY , *COLONOSCOPY , *PAIN , *PATIENT satisfaction - Abstract
Background: Fear of pain and sedation-related adverse events are impediments for patients to attend endoscopic screening or surveillance programs. Objective: To investigate the long-term effect of different sedation protocols in patients undergoing screening or surveillance endoscopy. Moreover, motivation of patients to decline endoscopic procedures was evaluated by focusing on the patient's satisfaction, fear and pain in relation to type of sedation used. Methods: Design: A prospective, double-blind controlled trial data collection was performed by using a standardized clinical questionnaire followed by a telephone interview 3-4 weeks after the initial endoscopic procedure. Setting: The study was conducted at the Department of Medicine I at the University Hospital of Erlangen-Nuremberg. Data collection was performed during June 2012 till April 2013. Patients: Overall, 307 patients were prospectively evaluated (44.3% female, mean age 51 ± 17.4 years; mean BMI 25.5 ± 5.7). 247 patients (80.5%) were outpatients, 60 inpatients (19.5%). Interventions: Endoscopic procedures were divided into five groups: (i) procedures in the upper gastrointestinal tract, (ii) complete colonoscopies, (iii) ileocolonoscopies, (iv) incomplete colonoscopies, and (v) other procedures. Main outcome measurements: Patient satisfaction, fear and pain were measured in a structured and standardized clinical interview using a 6-point numerical rating scale, where 1 was 'very satisfied/no pain' and 6 was 'very unsatisfied/unsupportable pain'. Results: Different types of sedation were assessed: propofol in monosedation (6.5%), combination of propofol + meperidine (41.0%), combination of midazolam + meperidine (48.5%) and other combinations (3.9%). Patient satisfaction was significantly reduced regarding fear and pain during the endoscopic procedure (p = 0.001 and p = 0.0001, respectively). All patients receiving propofol monosedation indicated significantly less pain in comparison to other sedation groups (p < 0.0001). Moreover, sedation with midazolam + meperidine increased the fear during the procedure significantly in comparison to monosedation with propofol (p = 0.082). Propofol/meperidine in combination and midazolam/meperidine increased the probability for cardiovascular events in comparison to monosedation with propofol (p = 0.005; p = 0.039). Finally, we observed significantly lower doses of propofol when used in monosedation than propofol in combination with meperidine (p = 0.066). Limitation: Single-center study at a tertiary referral center. Conclusions: Propofol in monosedation should preferably be used for patient sedation in screening and surveillance endoscopies. Whether this approach could also improve participation rates in screening and surveillance endoscopies requires further investigations. © 2014 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
97. Extensive small-bowel Crohn's disease detected by the newly introduced 360° panoramic viewing capsule endoscopy system.
- Author
-
Tontini, Gian Eugenio, Cavallaro, Flaminia, Neumann, Helmut, Pastorelli, Luca, Neurath, Markus F, Spina, Luisa, and Vecchi, Maurizio
- Published
- 2014
- Full Text
- View/download PDF
98. The esophageal mucosa and submucosa: immunohistology in GERD and Barrett's esophagus.
- Author
-
Appelman, Henry D., Streutker, Catherine, Vieth, Michael, Neumann, Helmut, Neurath, Markus F., Upton, Melissa P., Sagaert, Xavier, Wang, Helen H., El ‐ Zimaity, Hala, Abraham, Susan C., and Bellizzi, Andrew M.
- Subjects
- *
GASTROINTESTINAL mucosa , *IMMUNOHISTOCHEMISTRY , *BARRETT'S esophagus , *GASTROESOPHAGEAL reflux treatment , *CANCER invasiveness , *ADENOCARCINOMA , *TRANSCRIPTION factors - Abstract
This paper presents commentaries on the microscopic morphology of esophageal squamous epithelium; the frequency of duplication of the muscularis mucosae (MM) in Barrett's esophagus (BE); the significance of multilayered epithelium; whether cells in the lamina propria reflect those in the epithelium; how stem cells are identified in the squamous esophagus; dilated intercellular spaces; the metastasizing potential of early carcinoma-dependent, molecular or immunohistochemical tests that improve diagnosis; the role of immunohistochemistry IHC in grading of neoplasia in Barrett's esophagus and defining the risk of progression to adenocarcinoma; the roles of CDX1 and CDX2 in squamous and cardiac mucosa; and the role of desmosomal cadherins and lectins in squamous and cardiac mucosa. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
99. Tissue resistance in the normal and diseased esophagus.
- Author
-
Bellizzi, Andrew M., Nardone, Gerardo, Compare, Debora, Bor, Serhat, Capanoglu, Doga, Farré, Ricard, Neumann, Helmut, Neurath, Markus F., Vieth, Michael, Chen, Hao, and Chen, Xiaoxin
- Subjects
- *
ESOPHAGUS diseases , *GASTROESOPHAGEAL reflux , *EPITHELIUM , *INFLAMMATION , *MICROSCOPY , *DEVELOPMENTAL biology - Abstract
This paper presents commentaries on reflux-induced injury of human esophageal epithelium; inflammation in human reflux esophagitis; motor consequences of reflux-induced inflammation in esophageal epithelium; the microscopic morphology of esophageal squamous epithelium; intraluminal impedance in the evaluation of the esophageal mucosa; endoscopic tissue morphology of esophageal squamous epithelium; and the developmental biology of esophageal squamous epithelium. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
100. GERD assessment including pH metry predicts a high response rate to PPI standard therapy.
- Author
-
Kandulski, Arne, Peitz, Ulrich, Mönkemüller, Klaus, Neumann, Helmut, Weigt, Jochen, and Malfertheiner, Peter
- Subjects
- *
GASTROESOPHAGEAL reflux diagnosis , *PROTON pump inhibitors , *GASTROESOPHAGEAL reflux , *ESOPHAGOSCOPY , *ESOMEPRAZOLE , *DEGLUTITION disorders , *ESOPHAGOGASTRIC junction , *PATIENTS - Abstract
Background: Inadequate response to proton pump inhibitor (PPI) therapy in patients with gastroesophageal reflux disease (GERD) is reported in up to 40%. Patients with non erosive reflux disease (NERD) have lower response rates compared to patients with erosive reflux disease (ERD); pH metry contributes to GERD diagnosis and is critical for proper diagnosis of NERD. Aim of the study was to assess the need for doubling esomeprazole standard dose (40 mg) for 4 weeks in PPI naive patients with typical reflux symptoms and diagnosis of GERD based on endoscopy and 48 hours, wireless pH metry. Methods: All patients underwent upper GI endoscopy. Symptoms were recorded with a structured questionnaire (RDQ) and acid exposure was determined by 48 hours, wireless pH monitoring (BRAVO). In case of abnormal acid exposure, patients received a short term treatment with esomeprazole 40 mg q.d. for 4 weeks. If symptoms persisted, patients underwent a second pH metry on PPI and the dose was increased to 40 mg b.i.d. Results: 31 consecutive patients with typical reflux symptoms underwent 48 hours pH monitoring. 22 patients (71%) had abnormal acid exposure, 9 patients had normal pH metry (29%). Of the 9 patients with normal pH metry, 2 were found with erosive esophagitis and 7 without endoscopic abnormalities. 24 patients with documented GERD received esomeprazole treatment. 21 patients achieved complete symptom resolution with 40 mg q.d. after 4 weeks (88%). Only 2 patients required doubling the dose of esomeprazole for complete symptom resolution, 1 patient remained with symptoms. Conclusions: Patients with typical reflux symptoms and abnormal acid exposure have a high response rate to standard dose esomeprazole regardless of whether they have ERD or NERD. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.